Survey to Assess International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hematopoietic Stem Cell Transplant
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 519
- Locations
- 1
- Primary Endpoint
- prevalence of international travel
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant. This information will help to improve the understanding of the needs for travel health strategies and interventions to provide healthy and safe travel to HSCT patients. The findings of this survey will also be used to develop travel health related interventions for patients living with cancer as well.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Hematopoietic Stem Cell Transplant (HSCT) recipients at MSKCC from 1/1/2005 to 12/31/
- •Age at HSCT ≥ 18 years
- •Permanent mailing address in the United States of America
Exclusion Criteria
- •Subject unable to fill the questionnaire due to language barriers.
Outcomes
Primary Outcomes
prevalence of international travel
Time Frame: 2 years
of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT
Secondary Outcomes
- international travel was during a high-risk specific period(2 years)
- patients that sought pre-travel health advice(2 years)
- travelers that becomes ill and required medical attention(2 years)